Concentrix (NASDAQ:CNXC) Issues Q3 2026 Earnings Guidance

Concentrix (NASDAQ:CNXC) issued an update on its third quarter 2026 earnings guidance on Monday. The company provided EPS guidance of 2.650-2.770 for the period, compared to the consensus estimate of 3.040. The company issued revenue guidance of $2.5 billion-$2.5 billion, compared to the consensus revenue estimate of $2.5 billion. Concentrix also updated its FY 2026 guidance to 10.830-11.180 EPS.

Concentrix Stock Up 0.9%

Shares of CNXC stock traded up $0.23 during trading hours on Monday, reaching $25.23. 3,243,255 shares of the stock were exchanged, compared to its average volume of 1,609,831. The company has a debt-to-equity ratio of 1.43, a current ratio of 1.18 and a quick ratio of 1.18. Concentrix has a 12-month low of $22.05 and a 12-month high of $62.14. The firm has a market capitalization of $1.54 billion, a P/E ratio of -1.17, a P/E/G ratio of 0.31 and a beta of 0.43. The business’s fifty day moving average is $25.93 and its two-hundred day moving average is $32.17.

Analysts Set New Price Targets

A number of equities analysts recently commented on the stock. Barrington Research reiterated an “outperform” rating and set a $38.00 target price on shares of Concentrix in a research note on Monday, June 22nd. Wall Street Zen lowered shares of Concentrix from a “buy” rating to a “hold” rating in a research report on Saturday, March 28th. Weiss Ratings restated a “sell (d)” rating on shares of Concentrix in a research report on Monday, April 27th. Robert W. Baird cut their price objective on shares of Concentrix from $52.00 to $40.00 and set an “outperform” rating for the company in a research report on Wednesday, March 25th. Finally, Canaccord Genuity Group cut their target price on Concentrix from $80.00 to $55.00 and set a “buy” rating for the company in a research note on Wednesday, March 25th. Three research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. According to MarketBeat.com, Concentrix presently has a consensus rating of “Moderate Buy” and an average price target of $44.33.

Insiders Place Their Bets

In other news, major shareholder Bruxelles Lambert Groupe sold 6,000,000 shares of the company’s stock in a transaction on Wednesday, April 29th. The stock was sold at an average price of $22.25, for a total value of $133,500,000.00. Following the sale, the insider directly owned 2,773,667 shares in the company, valued at $61,714,090.75. This represents a 68.39% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Andre S. Valentine bought 2,500 shares of Concentrix stock in a transaction on Thursday, April 9th. The stock was purchased at an average price of $27.95 per share, for a total transaction of $69,875.00. Following the completion of the acquisition, the chief financial officer owned 89,066 shares in the company, valued at $2,489,394.70. This represents a 2.89% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders own 0.90% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in CNXC. Corient Private Wealth LLC acquired a new position in shares of Concentrix in the 4th quarter valued at about $289,000. Pacer Advisors Inc. lifted its position in shares of Concentrix by 73.2% during the fourth quarter. Pacer Advisors Inc. now owns 16,099 shares of the company’s stock worth $669,000 after purchasing an additional 6,804 shares in the last quarter. Invesco Ltd. boosted its holdings in Concentrix by 16.3% in the fourth quarter. Invesco Ltd. now owns 478,790 shares of the company’s stock valued at $19,908,000 after purchasing an additional 67,036 shares during the last quarter. SummitTX Capital L.P. boosted its stake in shares of Concentrix by 268.0% during the 4th quarter. SummitTX Capital L.P. now owns 45,780 shares of the company’s stock valued at $1,904,000 after buying an additional 33,340 shares during the last quarter. Finally, Twinbeech Capital LP bought a new position in Concentrix during the 4th quarter valued at $964,000. Institutional investors and hedge funds own 90.34% of the company’s stock.

About Concentrix

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.